Showing results (71-80 of 100) with videos related to
Sort By:
Pageof 10
The American Journal of Tropical Medicine and Hygiene|July 28, 2017
Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (<i>G6PD Mahidol</i> Variant) versus G6PD-Normal VolunteersRonnatrai Rueangweerayut, Germana Bancone, Emma J Harrell, et al.The Lancet. Microbe|June 2, 2022
Effectiveness of pyronaridine-artesunate against Plasmodium malariae, Plasmodium ovale spp, and mixed-Plasmodium infections: a post-hoc analysis of the CANTAM-Pyramax trialMirjam Groger, Gaston Tona Lutete, Ghyslain Mombo-Ngoma, et al.Plos Medicine|June 15, 2021
Pyronaridine-artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring studyGaston Tona Lutete, Ghyslain Mombo-Ngoma, Serge-Brice Assi, et al.The Lancet. Child & Adolescent Health|December 6, 2021
Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trialIván D Vélez, Tran T Hien, Justin A Green, et al.Malaria Journal|February 10, 2026
Severe malaria treatment with rectal artesunate and artemisinin-based combination therapy in remote settings: an effectiveness-implementation hybrid type 3 study protocol (SEMA ReACT)Sebastian Hachizovu, Christine Manyando, Michael Nambozi, et al.Emerging Infectious Diseases|June 17, 2015
Malaria Prevalence among Young Infants in Different Transmission Settings, AfricaSerign J Ceesay, Lamine Koivogui, Alain Nahum, et al.Antimicrobial Agents and Chemotherapy|April 6, 2016
Linking Murine and Human Plasmodium falciparum Challenge Models in a Translational Path for Antimalarial Drug DevelopmentJames S McCarthy, Louise Marquart, Silvana Sekuloski, et al.Malaria Journal|November 2, 2012
Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trialKassoum Kayentao, Ogobara K Doumbo, Louis K Pénali, et al.Malaria Journal|June 18, 2026
Point of care performance of the improved BIOCREDIT Ag Pf/Pv (pLDH/pLDH) rapid diagnostic test: a cross-sectional study at a health center setting in EthiopiaEshetu Molla, Eyob Fekadu, Zemed Biyazen, et al.Malaria Journal|June 29, 2026
Prevalence of antimalarial drug resistance markers and factors associated with Plasmodium falciparum infection in asymptomatic children prior to rectal artesunate implementation in Kapolowe Health District, Democratic Republic of the CongoFlory Luzolo Khote, Madalena Raposo, Tafadzwa Maseko, et al.Pageof 10